Search Results

Site Search

Mayo Clinic Laboratory and pathology research roundup: November 22 - Insights

This week's research roundup features: Progression of chronic kidney disease following radical and partial nephrectomy

Mayo Clinic Laboratory and pathology research roundup: January 24 - Insights

This weeks research roundup features: Automated scoring of total inflammation in renal allograft biopsies

Mayo Clinic Laboratory and pathology research roundup: January 31 - Insights

This week's research roundup features: Emergence of restless legs syndrome during opioid discontinuation

Mayo Clinic Laboratory and pathology research roundup: December 13 - Insights

This week's research roundup features: In vitro activity of a hypochlorous acid-generating electrochemical bandage against yeast biofilms

Mayo Clinic Laboratory and pathology research roundup: February 15 - Insights

This week's Research Roundup features: Activity of a hypochlorous acid-producing electrochemical bandage as assessed with a porcine explant biofilm model.

Mayo Clinic Laboratory and pathology research roundup: February 28 - Insights

This week's Research Roundup features: Laboratory and metabolic investigations.

Metacognitive Practices - Insights

Deb Hagen-Moe, Education Coordinator at Mayo Clinic, discusses how metacognition can be used to enhance an individual’s ability to learn and retain information.

Research Roundup Archives - Page 25 of 29 - Insights

Skip to Content MayoACCESS MayoLINK...

MLS Students Under the Microscope Archives - Insights

Skip to Content MayoACCESS MayoLINK...

Week in Review: June 3 - Insights

Today's highlights include: Spread of monkeypox underscores need for physicians to be ready to understand, Pfizer completes application to FDA for vaccine for children under 5, and connect is key to supporting multiple sclerosis patients.

COVID-19 weekly news: March 7-11 2022 - Insights

Topic's Include: Losing sleep during the pandemic? It may be affecting your weight, heart, and overall health, and how to deal with anxiety, stress when the world feels overwhelming.

Week in Review: April 29 - Insights

Today's highlights include: CDC estimates 3 in 4 kids have had coronavirus infections, virtual in-person cardiac rehabilitation provide similar benefits, and Mayo Clinic partners with AI startup to co-develop precision medicine.

Nonalcoholic Steatohepatitis (NASH)-FibroTest* [Test in Focus] - Insights

Nikola Baumann, Ph.D., gives an overview of the new NASH-FibroTest available through Mayo Clinic Laboratories. She discusses when this testing should be ordered, how this testing improves upon previous testing approaches, and what clinical...

Mayo Clinic's Accurate Amyloidosis Typing Test Leads to Effective Treatment - Insights

When the type of amyloidosis is appropriately determined by accurate and effective laboratory testing, it can be treated properly.

Growing Your Laboratory Through Outreach - Insights

Providing resources on how to best leverage and optimize your laboratory for patients, clients, and staff.

New tests launched in April - Insights

In April 2022, Mayo Clinic Laboratories announced fourteen new tests along with numerous reference value changes, obsolete tests, and algorithm changes.

Assay stratifies pregnant women's preeclampsia risk: Joshua Bornhorst, Ph.D. - Insights

Joshua Bornhorst, Ph.D., explains how Mayo Clinic Laboratories' unique assay identifies pregnant women at risk of developing preeclampsia with severe features. Test results can guide clinical management, to safeguard maternal and neonatal...

New tests launched in July - Insights

In July 2022, Mayo Clinic Laboratories announced fifteen new tests along with numerous reference value changes, obsolete tests, and algorithm changes.

Autoimmune Gastrointestinal Dysmotility Evaluation [Test in Focus] - Insights

Divyanshu (Div), Dubey, M.B.B.S, gives an overview of the new Autoimmune Gastrointestinal Dysmotility Evaluation available through Mayo Clinic Laboratories. He discusses when this testing should be ordered, how this testing compares to...

Assay identifies patients eligible for new ovarian cancer drug: Maryam Shahi, M.D. - Insights

Maryam Shahi, M.D., explains how Mayo Clinic Laboratories' unique biomarker test (TEST ID: AFOLR) determines which patients would likely benefit from a new treatment for recurrent epithelial ovarian cancer. Disease recurrence is common, and...

Urinary Steroid Profile [Test in Focus] - Insights

Irina Bancos, M.D. gives an overview of this test available through Mayo Clinic Laboratories. She discusses when this testing should be ordered, how this testing compares to other testing approaches, and what clinical action can be taken...

Mayo Clinic Laboratory and pathology research roundup: August 1 - Insights

This week's research roundup feature: A lncRNA from the FTO locus acts as a suppressor of the m6A writer complex and p53 tumor suppression signaling.

Mayo Clinic Laboratory and pathology research roundup: August 8 - Insights

This week's research roundup feature: Age-based versus young-adult thresholds for nephrosclerosis on kidney biopsy and prognostic implications for CKD.

Mayo Clinic Laboratory and pathology research roundup: July 18 - Insights

This week's research roundup feature: Natural history, predictors of development of extramedullary disease, and treatment outcomes for patients with extramedullary multiple myeloma.

Thanksgiving Specimen Shipping Guidelines and Schedule - Insights

Due to the Thanksgiving holiday (recognized on Thursday, Nov. 28), Mayo Clinic Laboratories' specimen pickup and delivery schedules will be altered. To ensure specimen stability and prevent delays, follow the guidelines outlined below for...

Severe storms affecting FedEx hub in Memphis, TN - Insights

Due to severe weather affecting the FedEx hub in Memphis, Tennessee, delays are anticipated. The Mayo Clinic Laboratories’ Global Logistics team will be diverting work to other commercial shipping options.  

Independence Day Specimen Shipping Guidelines and Schedule - Insights

Mayo Clinic Laboratories' specimen pickup and delivery schedules will be altered due to the upcoming July 4th holiday. To ensure specimen stability and prevent delays, follow the guidelines outlined below for domestic clients and...

Assay monitors response to monoclonal antibody therapy: Maria Alice Willrich, Ph.D. - Insights

Maria Alice Willrich, Ph.D., explains how Mayo Clinic Laboratories' new assay provides therapeutic drug monitoring of risankizumab, or RISA. Test results help guide care for patients with plaque psoriasis, psoriatic arthritis, and Crohn's...

Hepatitis C Virus Genotypic Antiviral Drug Resistance [Test in Focus] - Insights

Joseph Yao, M.D., gives an overview of this new test available through Mayo Clinic Laboratories. He discusses when this testing should be ordered, how this testing improves upon other testing approaches, and what clinical action can be...

Gastrointestinal Pathogen Panel, PCR, Feces [Test in Focus] - Insights

The new Gastrointestinal Pathogen Panel, PCR, Feces test is now available to the Mayo Clinic practice and Mayo Medical Laboratories clients.

Test helps identify elusive central nervous system pathogens: Robin Patel, M.D. - Insights

Robin Patel, M.D., explains how a new Mayo Clinic Laboratories' assay can identify central nervous system pathogens that standard tests fail to detect. Rapid, precise diagnosis is essential to preventing long-term effects from these...

Psychotropic PGx Panel for Drug Treatment Optimization [Test in Focus] - Insights

Ann Moyer, M.D., Ph.D. gives an overview of this new test available through Mayo Clinic Laboratories. She discusses when this testing should be ordered, how this testing improves upon other testing approaches, and what clinical action can...

New Test Options for NTRK Gene Fusions - Insights

The presence NTRK gene fusions is one of the eligibility requirements for the recently FDA-approved therapy Vitrakvi (larotrectinib), a therapy indicated in adult and pediatric patients with solid tumors regardless of the type of tumor....

Molecular Detection for Tuberculosis Drug Resistance [Test in Focus] - Insights

Nancy Wengenack, Ph.D. gives an overview of this test available through Mayo Clinic Laboratories. She discusses when this testing should be ordered, how this testing compares to other testing approaches, and what clinical action can be...

Cardiovascular Biomarkers of Atherosclerotic Risk - Insights

In this month’s “Hot Topic,” Vlad Vasile, M.D., Ph.D., reviews ceramides and their atherosclerotic risk through defining ceramides, talking about when they should be tested for and touch on the topic of ceramides in primary prevention.

STAT testing - Insights

STAT testing is available on a limited basis for patients with a suspected or known inborn error of metabolism when there is an increased risk of illness or death due to metabolic decompensation or when testing will allow for emergent...

Mayo Clinic Laboratory and Pathology Research Roundup: April 16 - Insights

This week's research roundup feature: R0 resection and radiation therapy have been associated with improved overall survival (OS) in patients with thymic carcinoma (TC). Here, we analyzed which subgroups of patients derive the greatest...

CPT codes and LOINC update: May 2024 - Insights

This page includes updates posted to Mayo Clinic Labs during the month of May.

CPT codes and LOINC update: March 2023 - Insights

This page includes updates posted to Mayo Clinic Labs during the month of March.

Microlearning: All the Small Things - Insights

As the saying often goes, “It’s the small things that matter the most.” Jeremy Zacher, Education Specialist in the Department of Laboratory Medicine and Pathology, discusses "microlearning" as a way of delivering learning content in...

QuantiFERON-TB Gold Plus - Insights

In this month’s “Hot Topic,” Elitza Theel, Ph.D. will discuss a new interferon-gamma release assay that can assist in the detection of individuals that are infected with tuberculosis.

New tests launched in March - Insights

In March 2023, Mayo Clinic Laboratories announced twenty nine new tests along with numerous reference value changes, obsolete tests, and algorithm changes.

Second-Tier Assay for MPS I Newborn Screening Shows Remarkable Reduction of False Positives - Insights

Mucopolysaccharidosis type I (MPS I) is a rare genetic disorder that typically presents with progressive multisystem involvement in early childhood. This condition results from the deficiency of the enzyme, alpha-L-iduronidase (IDUA), which...

November 2023 - Gastroenterology Pathology Case 2 - Insights

This "Pathways" program provides an Anatomic Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Gastroenterology Pathology.

Research - Insights

The exchange of medical knowledge is a founding principle of Mayo Clinic. William J. Mayo, M.D., said it best: “It is a great thing to make scientific discoveries of rare value, but it is even greater to be willing to share these...

What's New in Health Care Reform: Dec. 26 - Insights

Top highlights include: FDA panel backs prescribing opioid overdose reversal drug along with painkillers, Surgeon General warns youth vaping is now an "epidemic," international patients seeking cures in the states, Mayo Clinic President and...

Frozen and on Time: Rapid Margin Assessment Helps Prevent Repeat Surgeries - Insights

A breakthrough in pathology, achieved more than a century ago (allegedly on a frozen window ledge in Rochester, Minnesota) has evolved into an innovative aspect of care at Mayo Clinic. Mayo is one of the only medical centers in the United...

Mayo Clinic Laboratory and Pathology Research Roundup: Sept. 17 - Insights

This week’s Research Roundup highlights the risk of MGUS in relatives of multiple myeloma cases by clinical and tumor characteristics.

Research Roundup Archives - Page 19 of 28 - Insights

Skip to Content MayoACCESS MayoLINK...

Mayo Clinic Laboratory and Pathology Research Roundup: Oct. 15 - Insights

This week’s Research Roundup highlights paraneoplastic neuronal intermediate filament autoimmunity.